Jorge M. Otero

Bogota, DC, Colombia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Sarcopenia and postoperative outcomes in patients with peritoneal carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Sarcopenia and postoperative outcomes in patients with peritoneal carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Journal: Abdominal radiology (New York)

Published: December 23, 2025

Molecular and clonal evolution of primary lesions vs. brain metastasis in EGFR-mutated NSCLC: a retrospective cohort study.

Molecular and clonal evolution of primary lesions vs. brain metastasis in EGFR-mutated NSCLC: a retrospective cohort study.

Journal: Translational lung cancer research

Published: April 29, 2025

Molecular Tumor Board Improves Outcomes for Hispanic Patients With Advanced Solid Tumors.

Molecular Tumor Board Improves Outcomes for Hispanic Patients With Advanced Solid Tumors.

Journal: JCO global oncology

Published: January 18, 2024

Application of Comprehensive Genomic Profiling-Based Next-Generation Sequencing Assay to Improve Cancer Care in a Developing Country.

Application of Comprehensive Genomic Profiling-Based Next-Generation Sequencing Assay to Improve Cancer Care in a Developing Country.

Journal: Cancer control : journal of the Moffitt Cancer Center

Published: May 06, 2023

Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC): Results of an Observational Longitudinal Cohort Study.

Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC): Results of an Observational Longitudinal Cohort Study.

Journal: Targeted oncology

Published: February 19, 2023

Mechanisms of Resistance to First-Line Osimertinib in Hispanic Patients With EGFR Mutant Non-Small Cell Lung Cancer (FRESTON-CLICaP).

Mechanisms of Resistance to First-Line Osimertinib in Hispanic Patients With EGFR Mutant Non-Small Cell Lung Cancer (FRESTON-CLICaP).

Journal: Clinical lung cancer

Published: March 25, 2022

EGFR Inhibitors Plus Bevacizumab are Superior Than EGFR Inhibitors Alone as First-Line Setting in Advanced NSCLC With EGFR Mutations and BIM Deletion Polymorphisms (BIM-CLICaP).

EGFR Inhibitors Plus Bevacizumab are Superior Than EGFR Inhibitors Alone as First-Line Setting in Advanced NSCLC With EGFR Mutations and BIM Deletion Polymorphisms (BIM-CLICaP).

Journal: JCO precision oncology

Published: January 07, 2022

Human papillomavirus infection and lung adenocarcinoma: special benefit is observed in patients treated with immune checkpoint inhibitors.

Human papillomavirus infection and lung adenocarcinoma: special benefit is observed in patients treated with immune checkpoint inhibitors.

Journal: ESMO open

Published: December 15, 2021

p.G12C KRAS mutation prevalence in non-small cell lung cancer: Contribution from interregional variability and population substructures among Hispanics.

p.G12C KRAS mutation prevalence in non-small cell lung cancer: Contribution from interregional variability and population substructures among Hispanics.

Journal: Translational oncology

Published: November 01, 2021

Prognostic significance of telomerase reverse transcriptase promoter gen mutations in high grade meningiomas

Prognostic significance of telomerase reverse transcriptase promoter gen mutations in high grade meningiomas

Journal: Biomedica : revista del Instituto Nacional de Salud

Published: April 06, 2021

Impact of COVID-19 Infection on Patients with Cancer: Experience in a Latin American Country: The ACHOCC-19 Study.

Impact of COVID-19 Infection on Patients with Cancer: Experience in a Latin American Country: The ACHOCC-19 Study.

Journal: The oncologist

Published: February 02, 2021

Genotyping Squamous Cell Lung Carcinoma in Colombia (Geno1.1-CLICaP).

Genotyping Squamous Cell Lung Carcinoma in Colombia (Geno1.1-CLICaP).

Journal: Frontiers in oncology

Published: July 29, 2020

Showing 1-12 of 35

Last Updated: 09/26/2026